
Commentary|Videos|August 4, 2025
Molecular Testing in Lung Cancer: Personalized Diagnostics Are Transforming Care
Author(s)Luis E Raez, MD, FASCO, FACP
Luis E. Raez, MD, FACP, FASCO, dives into evolving practices in molecular testing for patients with lung cancer.
Advertisement
Luis E. Raez, MD, FACP, FASCO, dives into the evolving use of molecular testing for patients with lung cancer. Raez is the medical director of Memorial Cancer Institute, oncology research director of Memorial Health Care System, and director of the Thoracic Oncology Program at the Florida Society of Clinical Oncology. He is also a clinical associate professor of medicine at Florida International University and a visiting professor of medicine at Cayetano Heredia University in Peru.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026
2
ADCs Reshape the Future of Lung Cancer Care: From Second-Line Therapy to Earlier Intervention
3
FDA Approves Zenocutuzumab for NRG1 Fusion+ Cholangiocarcinoma
4
Daraxonrasib Monotherapy Elicits Meaningful Responses in Previously Treated, RAS-Mutated Pancreatic Cancer
5




















































